http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
-
Motus GI Holdings (MOTS) Granted FDA Clearance to Market the Pure-Vu
-
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
-
Motus GI to Host Innovation Day Highlighting the Pure-Vu EVS System
-
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features
-
Motus GI to Present at Two Upcoming Investor Conferences in December 2021
-
Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
Motus GI to Release Third Quarter Results and Provide a Business Update on November 12
-
Motus GI Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting
-
Motus GI Announces the Passing of Independent Director Dr. Sam Nussbaum
-
Motus GI to Present at the Oppenheimer & Co. Inc. Fall Healthcare Summit
-
Motus GI Announces Enrollment of Patients at Second Site in the European Union Outpatient Study of the Pure-Vu® System
-
Motus GI to Participate in Two Upcoming Investor Conferences in September 2021
-
Motus GI Reports Second Quarter 2021 Financial Results and Provides Corporate Update
-
Motus GI to Release Second Quarter Results and Provide a Business Update on August 12
-
Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy
-
Motus GI to Present at the Ladenburg Thalmann Healthcare Conference
-
Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Audit Committee
-
Motus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation
-
Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology
-
Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore
-
Motus GI Reports First Quarter 2021 Financial Results and Provides Corporate Update
-
Motus GI Announces Publication of a Pure-Vu System® Cost Effectiveness Analysis in the Journal of Cost Effectiveness and Resource Allocation
-
Motus GI Holdings (MOTS) Receives FDA Clearance to Market the Pure-Vu System for Upper GI Endoscopy
-
Motus GI Receives FDA Clearance to Market the Pure-Vu® System for Upper GI Endoscopy
-
Motus GI to Release First Quarter Results and Provide a Business Update on May 13
-
Motus GI Holdings (MOTS) Submits 510(k) Application to FDA for the Pure-Vu System for Upper GI Endoscopy
-
Motus GI Submits 510(k) Application to FDA for the Pure-Vu System for Upper GI Endoscopy
-
Motus GI Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
-
Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center
-
Motus GI to Present Pure-Vu GEN2 System at the Centers for Medicare and Medicaid Services ICD-10 Reimbursement Code Committee Meeting
-
Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16
-
Motus GI Announces U.S. Patent for the Pure-Vu® System’s Connectivity with Nearly All Commercial Colonoscopes to Provide Improved Visualization During Colonoscopy
-
Motus GI Holdings (MOTS) Announces European Clearance of Enhanced Pure-Vu® GEN2 System to Harmonize with U.S. Configuration
-
Motus GI Announces European Clearance of Enhanced Pure-Vu® GEN2 System to Harmonize with U.S. Configuration
-
Motus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Universal Method to Mount on the End of Most Commercial Colonoscopes
-
Motus GI Announces Clinical Compendium of Pure-Vu System Patient Case Studies As Reported by Several Leading U.S. Hospitals
-
Motus GI and Memorial Hermann Hospital Partner to Improve its Colonoscopy Efficiencies
-
Motus GI Scheduled to Participate in the Piper Sandler 32nd Annual Healthcare Conference
-
Motus GI Reports Third Quarter 2020 Financial Results and Provides Corporate Update
-
Motus GI and NYU Langone Health Partner to Improve its Inpatient Colonoscopy Management
-
Motus GI to Release Third Quarter 2020 Results and Provide a Business Update on November 12
-
Motus GI Hosting Key Opinion Leader Call on Improving Endoscopy Outcomes with the Pure-Vu® System
-
Motus GI Holdings (MOTS) Expands Intellectual Property Portfolio with Chinese Patent for its Method to Mount the Pure-Vu® System on the End of a Colonoscope
-
Motus GI Expands Intellectual Property Portfolio with Chinese Patent for its Method to Mount the Pure-Vu® System on the End of a Colonoscope
-
Motus GI Scheduled to Present at Investor Conferences in September 2020
-
Motus GI Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
Motus GI to Release Second Quarter 2020 Results and Provide a Business Update on August 11th
-
Motus GI Launches Mobile App to Provide On-Demand Support and Resources to Hospitals Using the Pure-Vu® System
-
Motus GI to Present at the Virtual Investor Fireside Chat Series

